Publication Cover
Mycology
An International Journal on Fungal Biology
Volume 14, 2023 - Issue 3
1,549
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Risk factors and mortality of the newly emerging Candida auris in a university hospital in Saudi Arabia

ORCID Icon
Pages 256-263 | Received 11 Apr 2023, Accepted 14 Jun 2023, Published online: 29 Jun 2023

References

  • Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, Roodgari S, Kiakojuri K, Al-Hatmi AMS, Meis JF, Badali H. 2019. Candida auris otomycosis in Iran and review of recent literature. Mycoses. 62(2):101–105. doi:10.1111/myc.12886.
  • Almaghrabi RS, Albalawi R, Mutabagani M, Atienza E, Aljumaah S, Gade L, Forsberg K, Litvintseva A, Althawadi S. 2020. Molecular characterisation and clinical outcomes of Candida auris infection: single-centre experience in Saudi Arabia. Mycoses. 63(5):452–460. doi:10.1111/myc.13065.
  • Alshamrani MM, El-Saed A, Mohammed A, Alghoribi MF, Al Johani SM, Cabanalan H, Balkhy HH. 2021. Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia. Infect Control Hosp Epidemiol. 42(2):149–155. doi:10.1017/ice.2020.414.
  • Arendrup MC, Patterson TF. 2017. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 216(suppl_3):S445–S451. doi:10.1093/infdis/jix131.
  • Bing J, Wang S, Xu H, Fan S, Du H, Nobile CJ, Huang G. 2022. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology. 13(1):68–75. doi:10.1080/21501203.2021.1994479.
  • Borman AM, Szekely A, Johnson EM, Mitchell AP. 2016. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen candida auris and other key pathogenic Candida species. mSphere. 1(4):e00189–16. doi:10.1128/mSphere.00189-16.
  • Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med. 4(165):165rv113. doi:10.1126/scitranslmed.3004404.
  • Centers for Disease Control and Prevention. 2019. Candida auris: General information about Candida auris. [Atlanta (GA)]: CDC; [accessed 2023 Mar 24]. https://www.cdc.gov/fungal/candida-auris/candida-auris-qanda.html.
  • Centers for Disease Control and Prevention. 2021. Candida auris: Information for laboratorians and health professionals. [Atlanta (GA)]: CDC; [accessed 2023 Mar 24]. https://www.cdc.gov/fungal/candida-auris/health-professionals.html.
  • Centers for Disease Control and Prevention. 2022. Candida auris: Identification of Candida auris. [Atlanta (GA)]: CDC; [accessed 2023 Mar 24]. https://www.cdc.gov/fungal/diseases/candidiasis/recommendations.html.
  • Chowdhary A, Sharma A. 2020. The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic. J Glob Antimicrob Resist. 22:175–176. doi:10.1016/j.jgar.2020.06.003.
  • Clancy CJ, Nguyen MH. 2017. Emergence of Candida auris: an International Call to Arms. Clin Infect Dis. 64(2):141–143. doi:10.1093/cid/ciw696.
  • Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G, Xue C. 2020. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 16(10):e1008921. doi:10.1371/journal.ppat.1008921.
  • Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, et al. 2018. A candida auris outbreak and its control in an intensive care setting. N Engl J Med. 379(14):1322–1331. doi:10.1056/NEJMoa1714373
  • Griffith N, Danziger L. 2020. Candida auris urinary tract infections and possible treatment. Antibiotics (Basel). 9(12):898. doi:10.3390/antibiotics9120898.
  • Hori Y, Shibuya K. 2018. Role of FKS gene in the susceptibility of pathogenic fungi to echinocandins. Med Mycol J. 59(2):E31–E40. doi:10.3314/mmj.18.004.
  • Hu S, Zhu F, Jiang W, Wang Y, Quan Y, Zhang G, Gu F, Yang Y. 2021. Retrospective analysis of the clinical characteristics of Candida auris infection worldwide from 2009 to 2020. Front Microbiol. 12:658329.
  • Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, Candida Auris Incident Management T, Manuel R, Brown CS. 2017. Candida auris: a review of the literature. Clin Microbiol Rev. 31(1):e00029–17.
  • Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, et al. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 64(2):134–140.
  • Lone SA, Ahmad A. 2019. Candida auris-the growing menace to global health. Mycoses. 62(8):620–637.
  • Lowe H, Woodd S, Lange IL, Janjanin S, Barnet J, Graham W. 2021. Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study. Confl Health. 15(1):94.
  • Magnasco L, Mikulska M, Giacobbe DR, Taramasso L, Vena A, Dentone C, Dettori S, Tutino S, Labate L, Di Pilato V, et al. 2021. Spread of carbapenem-resistant gram-negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms. 9(1):95.
  • McCarthy MW, Walsh TJ. 2017. Containment strategies to address the expanding threat of multidrug-resistant Candida auris. Expert Rev Anti Infect Ther. 15(12):1095–1099.
  • Mirhendi H, Charsizadeh A, Aboutalebian S, Mohammadpour M, Nikmanesh B, de Groot T, Meis JF, Badali H. 2022. South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature. Mycoses. 65(2):134–139.
  • Morales-Lopez SE, Parra-Giraldo CM, Ceballos-Garzon A, Martinez HP, Rodriguez GJ, Alvarez-Moreno CA, Rodriguez JY. 2017. Invasive infections with multidrug-resistant yeast Candida auris. Colombia. Emerg Infect Dis. 23(1):162–164.
  • Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, Edwards K, Rivera M, Shugart A, Walters M, et al. 2021. Candida auris outbreak in a COVID-19 specialty care unit. MMWR Morb Mortal Wkly Rep. 70(2):56–57.
  • Rossow J, Ostrowsky B, Adams E, Greenko J, McDonald R, Vallabhaneni S, Forsberg K, Perez S, Lucas T, Alroy KA, et al. 2021. Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units. Clin Infect Dis. 72(11):e753–e760.
  • Ruiz Gaitan AC, Moret A, Lopez Hontangas JL, Molina JM, Aleixandre Lopez AI, Cabezas AH, Mollar Maseres J, Arcas RC, Gomez Ruiz MD, Chiveli MA, et al. 2017. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol. 34(1):23–27.
  • Sayeed MA, Farooqi J, Jabeen K, Awan S, Mahmood SF. 2019. Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan. BMC Infect Dis. 19(1):384.
  • Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, et al. 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 5:35.
  • Todd B. 2017. Clinical alert: candida auris. Am J Nurs. 117(4):53–55.
  • Vaseghi N, Sharifisooraki J, Khodadadi H, Nami S, Safari F, Ahangarkani F, Meis JF, Badali H, Morovati H. 2022. Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): a systematic review and meta-analysis. Mycoses. 65(7):683–703.
  • Vinuela-Sandoval L, Falces-Romero I, Garcia-Rodriguez J, Eiros-Bouza JM. 2018. Candidemia and colonization by Candida auris, a diagnostic challenge. Enferm Infecc Microbiol Clin (Engl Ed). 36(4):253–255.